MedTrace Logo

Shared Decision Making in Patients With Lung Cancer

NCT05191485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 190

Last updated 2026-04-30

No results posted yet for this study

Summary

The objective of this study is to develop a Decision Aid for Lung Cancer Molecular Testing (DA\_LCMT) and to facilitate shared-decision making in patients who were diagnosed with lung adenocarcinoma by intraoperative frozen pathology about whether to conduct the molecular testing.

Conditions

Interventions

OTHER

Qualitative interviews

We will conduct semi-structured interviews with target patients, patients' representatives and other stakeholders to assess their decisional needs. The cognitive debriefing interview will start afterwards, and participants will answer probing questions asked by interviewers about DA\_LCMT 1.0. Then the field testing interviews will conducted one-on-one structured interviews.

Sponsors & Collaborators

  • Jiangyou People's Hospital

    collaborator UNKNOWN

  • Wu Jieping Medical Foundation

    collaborator OTHER

  • Chongqing Medical University

    collaborator OTHER

  • The Third People's Hospital of Chengdu

    collaborator OTHER

  • Sichuan Cancer Hospital and Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-22
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05191485 on ClinicalTrials.gov